Nano-X Imaging (NNOX) FDA Submission a 'Significant Regulatory Step' - Cantor Fitzgerald
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Ladenburg Thalmann Reiterates Buy Rating on Nano-X Imaging (NNOX) on 510(k) Submission
June 17, 2021 10:03 AM EDTLadenburg Thalmann analyst Jeffrey Cohen reiterated a Buy rating and $52.00 price target on Nano-X Imaging (NASDAQ: NNOX) after the company announced a 510(k) submission for the first version of the multisource Nanox-ARC digital tomosynthesis system to the FDA.
Cohen notes the typcical review... More
Nanox (NNOX) Announces FDA 510(k) Submission for First Version of Multi-Source Nanox.ARC
June 17, 2021 7:39 AM EDTNANOX IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, announced today that the Company has submitted a 510(k) premarket notification application to the U.S. Food and Drug Administration (FDA) for the first version of its multi-source Nanox.ARC 3-D digital tomosynthesis system.
... More
